Research studies on varicose veins matter because they tell us what actually works—and what doesn't. When doctors study treatments through clinical trials, they're collecting real data from real patients to see which approaches produce better results, cause fewer side effects, and last longer. This information shapes how doctors treat varicose veins today and influences what treatments might be available tomorrow.
Learn About Paying Your FGUA Bill Online →
Varicose veins affect roughly 20 percent of the adult population in the United States, making them one of the most common vascular conditions. Yet treatment approaches vary significantly from doctor to doctor, region to region. Some patients get recommended for surgical procedures called vein stripping, others for minimally invasive techniques like endovenous ablation, and still others for conservative management like compression stockings. These differences often come down to what research has shown to be effective in specific situations.
Understanding the research landscape helps patients have better conversations with their doctors. When you know what studies have tested, what outcomes researchers tracked, and what limitations exist in current evidence, you can ask more targeted questions about why a particular treatment is being recommended for your situation. You might learn that a newer technique has been studied in only a small number of patients, or that a traditional approach has decades of follow-up data behind it.
The research world around varicose veins includes multiple types of studies: large randomized controlled trials that compare two treatments head-to-head, observational studies that track what happens to patients who receive a particular treatment, and systematic reviews that pool data from many studies to identify patterns. Each type answers different questions and carries different weight in the medical literature.
Takeaway: Research studies form the foundation of modern vein treatment recommendations. Learning about what has been studied, how, and with what results gives you a framework for understanding the options your doctor presents.
Several landmark studies have fundamentally changed how doctors approach varicose veins over the past fifteen years. The EVRA trial (Endovenous versus Conventional Stripping in the Treatment of Primary Varicose Veins), conducted across multiple centers in the United Kingdom and published in 2003, compared traditional surgical vein stripping against newer endovenous techniques. The study followed 500 patients and found that endovenous ablation—using heat delivered through a catheter to seal the vein—produced similar outcomes to surgery but with less pain, faster recovery, and fewer complications. This trial alone shifted practice patterns across Europe and North America.
Free Guide to Pay by Plate Illinois Billing →
The VEIN-STEMM Study (Venous Insufficiency Epidemiologic and Economic Model) provided population-level data about how varicose veins develop and progress. Rather than testing a specific treatment, this research tracked thousands of people over time to understand risk factors and natural disease progression. The study confirmed that genetics plays a strong role—if both parents have varicose veins, the risk jumps to approximately 90 percent. It also documented that while many people develop visible varicose veins, not everyone develops symptoms or complications.
More recent comparative trials have examined specific endovenous techniques against each other. Studies published between 2015 and 2020 compared radiofrequency ablation (RFA) with laser ablation (EVLA), exploring whether one heat source was definitively better than another. The general finding: both work comparably well, though individual patient factors and vein characteristics might make one more suitable than the other in specific cases. What differs is the discomfort during the procedure and the likelihood of bruising afterward.
The AESAP trial (American Endovenous Surgery Association Patient registry) represents ongoing real-world evidence collection. Rather than a single one-time study, this is a registry where participating vascular surgeons and interventional radiologists continuously log patient outcomes from endovenous procedures. As of 2023, it includes data on over 50,000 procedures, providing practitioners with contemporary, practical information about success rates and complication patterns.
Takeaway: Major trials have repeatedly demonstrated that minimally invasive endovenous techniques achieve comparable or superior outcomes to traditional surgical vein stripping, with faster recovery. This evidence has shifted the standard of care, making it important context if your doctor recommends a particular approach.
When researchers conduct varicose vein studies, they must define what "success" means. This is trickier than it sounds, because varicose veins affect people differently. One patient cares most about the appearance of their leg, another primarily wants symptom relief (like reduced leg heaviness or cramping), and a third is mostly worried about preventing future complications like venous ulcers. Researchers trying to compare treatments need consistent measurements that apply across different patient groups.
Free Guide to Mold Removal Methods for Walls →
The most common measurement is anatomical success: did the targeted vein close? Researchers use ultrasound imaging to determine whether a treated vein remains patent (open) or is occluded (closed). Studies typically measure this at intervals—often at 1 week, 6 weeks, 6 months, and 1 year after treatment. Closure rates for modern endovenous ablation procedures are typically reported between 90-98 percent at one year, meaning the vast majority of treated veins stay sealed. This is one reason why endovenous techniques have become popular; the anatomical success rate is predictable and high.
Clinical success is different from anatomical success. A patient might report symptom improvement even if ultrasound shows some degree of vein reopening, or conversely, might have anatomical closure but persistent symptoms (sometimes because other, untreated veins are contributing). Researchers measure clinical success through validated questionnaires, the most common being the Venous Insufficiency Epidemiological and Economic Study Quality of Life (VEINES-QOL) questionnaire, which asks patients about pain, heaviness, swelling, and functional limitations. Studies typically report 60-90 percent of patients experiencing meaningful symptom improvement at 6-month follow-up.
Recurrence is another critical outcome. Some patients develop new varicose veins or experience reopening of treated veins over years. Distinguishing between true recurrence (a new problem developing) and persistent disease (the original problem never fully resolved) requires careful tracking. Long-term studies following patients 5 or even 10 years after treatment show that recurrence risk varies by technique, ranging from roughly 5-20 percent depending on the procedure and how rigorously researchers follow patients.
Complication rates are systematically tracked. Researchers document bruising, temporary nerve irritation, skin burns, and more serious but rare problems like deep vein thrombosis (blood clots in deeper veins). Modern studies report major complication rates under 2 percent for endovenous procedures, compared to historical rates closer to 5-10 percent for traditional surgery.
Takeaway: Research defines success in multiple ways—vein closure, symptom improvement, and freedom from complications. When discussing outcomes with your doctor, ask which measurements matter most for your personal situation, since different patients prioritize different goals.
Not all varicose vein research focuses on interventional procedures. A growing body of studies examines what happens when patients use conservative management—approaches that don't involve surgery or device-based treatment. These studies matter because many people have varicose veins but don't undergo procedures, and understanding what conservative approaches actually achieve is clinically relevant.
How to Delete Your Fitbit Account Guide →
Compression therapy—wearing graduated compression stockings that apply more pressure at the ankle and less at the thigh—has the longest research history. A 2018 systematic review published in the Cochrane Library examined 16 randomized trials examining compression stockings. The review found that compression does reduce symptoms like pain and heaviness, and that it may slow disease progression. However, the evidence quality was moderate, and compliance is a real-world challenge; many patients find stockings uncomfortable or inconvenient, leading to inconsistent use. Studies typically show symptom improvement while wearing stockings, but symptoms return when people stop wearing them.
Lifestyle modifications—weight loss, exercise, leg elevation—are frequently recommended but have surprisingly little direct research backing. A 2015 study published in the European Journal of Vascular and Endovascular Surgery examined physical activity and varicose vein progression in a large population cohort. The results were mixed; while increased activity was associated with slightly lower progression
This guide is for general information only and is not medical, financial, legal, or other professional advice. For decisions specific to your situation, consult a qualified professional. See our Editorial Policy.